Currax Pharmaceuticals is a patient-first, specialty biopharmaceutical company dedicated to expanding patient access to clinically differentiated prescription medicines worldwide. Currax is primarily focused on the number one and number two causes of preventable death in the U.S., smoking and obesity. Currax is committed to transforming the treatment of these diseases. Currax has over 20 products in its portfolio including CONTRAVE®, the number one prescribed branded oral weight-loss medication in the US. Currax is headquartered in Brentwood, TN. To learn more, please visit www.curraxpharma.com.